Presents:Case Presentation on Biomatrica,
the biostability company
Smart Strategies Needed for this Award-winning Green,
Life Sciences, High Tech Company
Life Sciences, High Tech Company
Date:
Wednesday, May 21, 2008
Time:
5:00pm - Networking Reception
6:00pm - Presentation and Q&A
8:00pm - End
Location:
The Salk Institute
10010 North Torrey Pines Road
La Jolla, CA 92037
Registration Fees:
MITEF Members and Sponsors: FREE (Registration Required)
Non-MITEF Members: $40
MIT Alumni: $25
Students: $15
Presenters:
Judy Cohn-Muller, Ph.D. -– President and CEO, Biomatrica
Rolf Muller, Ph.D. -- Chief Scientific Officer
Description:
With four products and a huge array of applications, how should Biomatrica direct its strategic product planning to insure maximum success? Related to this, how should they develop their board of directors to best serve the company's needs?
What type of channel strategy should Biomatrica be following? Direct sales channel, strategic partnering, and/or licensing?
Biomatrica® offers innovative technologies for stabilizing biological samples at room temperature. We have developed a novel platform technology designed for use in preserving complex biological samples and assays. Our current products stabilize DNA and RNA with no sample degradation, thus labs can reduce their reliance on freezers and drastically reduce shipping costs. Biomatrica products are used in laboratories performing life science research, from pharmaceutical and biotechnology companies to academic research and forensics laboratories.
Biomatrica received CONNECT's "Most Innovative New Product" Award in 2006.
Who should attend?
CEOs, entrepreneurs, strategic business consultants, marketing and other professionals from a variety of technolgoy segments (clean tech, life sciences, high tech) whowant to explore cross marketing opportunities and strategy development throught he enthusiasm of a CEO and CSO.
About the speakers:
(President and CEO) Judy Muller-Cohn, Ph.D. - Judy has twelve years of experience in bringing products for the life science industry to market and was involved in the development of numerous biotechnology companies. She was most recently a Director of Business Development at Digital Gene Technologies. Previously, she was a scientist at Mycogen/Dow AgroSciences where she brought basic research to the market. She received her doctorate at the Pasteur Institute in Paris, France. She has authored many papers and patents that paved the road to marketable products.
(Chief Scientific Officer) Rolf Muller, Ph.D. - Rolf has ten years of experience in starting biotechnology companies. He was most recently the Director of Assay Development and High Throughput Screening at the Scripps Research Institute. Previously, he was the Director of Molecular Biology at HK Pharmaceuticals and Digital Gene Technologies. He was also a scientist at the Salk Institute. Rolf obtained his doctorate at the Pasteur Institute in Paris, France. He has authored numerous publications and patents.
What type of channel strategy should Biomatrica be following? Direct sales channel, strategic partnering, and/or licensing?
Biomatrica® offers innovative technologies for stabilizing biological samples at room temperature. We have developed a novel platform technology designed for use in preserving complex biological samples and assays. Our current products stabilize DNA and RNA with no sample degradation, thus labs can reduce their reliance on freezers and drastically reduce shipping costs. Biomatrica products are used in laboratories performing life science research, from pharmaceutical and biotechnology companies to academic research and forensics laboratories.
Biomatrica received CONNECT's "Most Innovative New Product" Award in 2006.
Who should attend?
CEOs, entrepreneurs, strategic business consultants, marketing and other professionals from a variety of technolgoy segments (clean tech, life sciences, high tech) whowant to explore cross marketing opportunities and strategy development throught he enthusiasm of a CEO and CSO.
About the speakers:
(President and CEO) Judy Muller-Cohn, Ph.D. - Judy has twelve years of experience in bringing products for the life science industry to market and was involved in the development of numerous biotechnology companies. She was most recently a Director of Business Development at Digital Gene Technologies. Previously, she was a scientist at Mycogen/Dow AgroSciences where she brought basic research to the market. She received her doctorate at the Pasteur Institute in Paris, France. She has authored many papers and patents that paved the road to marketable products.
(Chief Scientific Officer) Rolf Muller, Ph.D. - Rolf has ten years of experience in starting biotechnology companies. He was most recently the Director of Assay Development and High Throughput Screening at the Scripps Research Institute. Previously, he was the Director of Molecular Biology at HK Pharmaceuticals and Digital Gene Technologies. He was also a scientist at the Salk Institute. Rolf obtained his doctorate at the Pasteur Institute in Paris, France. He has authored numerous publications and patents.
Date:
Wednesday, May 21, 20085:00AM-8:00PM
Add to Calendar
Location:
10010 North Torrey Pines RoadLa Jolla, CA 92037
